References

Citations

  1. Abel E, Lebwohl M (2008). Psoriasis. In EG Nabel, ed., ACP Medicine, section 2, chap. 3. Hamilton, ON: BC Decker.

  2. Puchalsky D (2011). Papulosquamous eruptions-Psoriasis. In ET Bope et al., eds., Conn’s Current Therapy 2011, pp. 823-827. Philadelphia: Saunders.

  3. Fortes C, et al. (2005). Relationship between smoking and the clinical severity of psoriasis. Archives of Dermatology, 141: 1580-1584.

  4. Abramowicz M (2008). Drugs for acne, rosacea and psoriasis. Treatment Guidelines From The Medical Letter, 6(75): 75-82.

Other Works Consulted

  • Aloe (2010). In A DerMarderosian, J Beutler, eds., Review of Natural Products. St. Louis: Wolters Kluwer Health.

  • Giezen TJ, et al. (2008). Safety-related regulatory actions for biologicals approved in the United States and the European Union. Journal of the American Medical Association, 300(16): 1887-1896.

  • Kimball AB, et al. (2008). National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. Journal of the American Academy of Dermatology, 58(6): 1031-1042.

  • Lebwohl MG, Kerkhof P (2010). Psoriasis. In MG Lebwohl et al., eds., Treatment of Skin Disease: Comprehensive Therapeutic Strategies, 3rd ed., pp. 626-636. Edinburgh: Saunders Elsevier.

  • Nestle FO, et al. (2009). Psoriasis. New England Journal of Medicine, 361(5): 496-509.

  • Schmitt J, et al. (2008). Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: Meta-analysis of randomized controlled trials. British Journal of Dermatology, 159(3): 513-526.

WebMD Medical Reference from Healthwise
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.© 1995-2015 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.